There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Like us and you'll find top breaking news in your Facebook newsfeed. Sign up for our daily email newsletter and get top stories and breaking news delivered to your inbox. MIDTOWNWe've commented before on the under-the-radar feel to Centurion, the...
To do this, samples from the 12 newborns were combined into a composite. Among the UCB donors, 6 were African American, 5 were Caucasian and one was Asian. Of the proteins detected in UCB, around 25 percent were previously detected in adults. Halden's...
Rolf Halden's team performs detailed analyses of umbilical cord blood (UCB), identifying a total of 1,210 proteins using mass spectroscopy. The findings represent a 6-fold increase in the number UCB proteins thus far described -- a significant advance:...
13 February 2012 Pial Ganguli Please Login to read the full article. UCB has entered into a multi-year strategic collaboration with private, Nodality, aimed at using the latter's single cell network profiling technology to "assist the development of...
(UCBJF) along with Nodality Inc. agreed for a strategic collaboration under which they will utilize Nodality’s proprietary Single Cell Network Profiling (SCNP) technology to develop several of UCB’s compounds. The multi-year agreement will initially be...
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological...
"This is a dramatic change to the pipeline for Vernalis." There are 35m prescriptions for cough and cold remedies in the US every year and there is only one slow-release product on the market, UCB's Tussionex. Vernalis' fundraising at 20p a share,...
Moreover, sales may be impacted by international and domestic trends toward managed care and health care cost containment and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and...
Employing more than 9000 people in over 40 countries, UCB produced revenue of EUR 3.22 billion in 2010. UCB is listed on Euronext Brussels (symbol: UCB). This press release contains forward-looking statements based on current plans, estimates and...
Today’s question we posed to the web: What Cardinal do you expect to be the biggest flop in 2012 for the Cardinals? Let’s go to the answers. Wow, that’s a tough one…I agree with Bill on Jay – the guy has yet to weather the doldrums of a full season as a...
UCB (United Cardinal Blogs) roundtable is back. Today's question we posed to the web: What Cardinal do you expect to be the biggest flop in 2012 for the Cardinals? Let's go to the answers. Cards N' Stuff: Wow, that's a tough one...I agree with Bill on...
“Earth is losing a huge amount of ice to the ocean annually, and these new results will help us answer important questions in terms of both sea rise and how the planet's cold regions are responding to global change,” UCB physics professor and study...
Dr. Arnaud reports receiving honoraria from Amgen and participating in conferences sponsored by GlaxoSmithKline; and Dr. Amoura, receiving honoraria from Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Neovacs, Roche, Teva Pharmaceuticals, and UCB...
Bronstein was not good for the Chron, although to be fair its shrinking subscriber base and advertising budget is something which impacts every print publication today. 2. The merger under Bronstein authority isn't "good" for investigative or local...
UCB opts for alliance as it picks Astellas as new Cimzia partner in Japan Today Ian Haydock Please Login to read the full article. UCB has wasted no time securing another partner for Cimzia (certolizumab pegol) in Japan following Otsuka Pharmaceutical's...
In addition, it is sufficient to achieve high recoveries if the Pfandbriefe default, justifying a one-notch uplift to 'AAA' for the Pfandbriefe rating. As of end-January 2012, UCB's outstanding mortgage covered bonds amounted to EUR25.4bn and were...
Therapeutics - Strategic Assessment 587.1 Key Events Impacting the Future Market 587.2 Ankylosing Spondylitis Therapeutics: Implications for Future Market Competition 598 Ankylosing Spondylitis Therapeutics - Future Players 608.1 Introduction 608.2 Company...
(UCBJF) and Japanese pharmaceutical company Astellas Pharma Inc. recently announced a collaboration to jointly develop and commercialize Cimzia (certolizumab pegol) for rheumatoid arthritis (RA) in Japan. According to the agreement, UCB will manufacture...
On today's new episode of Hitchin' a Ride, John Murray picks up Improv Everywhere's Charlie Todd to bring him to his show at the UCB Theatre, just a few blocks away. Unfortunately for Charlie, John had already picked up a couple of tourists and decided...
Fitch takes into account the lowest level of nominal OC observed in the last 12 months, which is 17.9% and is therefore higher than the OC supporting the 'AAA' rating of 12.7%. UCB's Pfandbrief rating is credit linked to Germany ('AAA'/Stable/'F1+') as...
UCB (Euronext: UCB), is a global biopharmaceutical manufacturer headquartered in Brussels. It focuses on novel therapeutic solutions for patients with severe diseases treated by specialists, particularly in the fields of central nervous system disorders (including epilepsy), inflammatory disorders (including allergy) and oncology. Full Article
BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB speaks onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB and singer Howie Dorough onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »The logo of Belgian drugmaker UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2011. The company warned on Wednesday that generic competition to its top epilepsy medicine would cause sales and profits to decline this year, after 2010 beat expectations due...
View Photo »Chief Financial Officer of Belgian drugmaker UCB, Detlef Thielgen, presents the company's 2010 results in Brussels March 2, 2011. UCB warned generic competition to its top epilepsy medicine would cause sales and profits to decline this year, after 2010 beat expectations due to strong...
View Photo »Executive Vice President of Belgian drugmaker UCB, Ismail Kola (L) and UCB 's Chief Executive Officer Roch Doliveux, present the company's 2010 results in Brussels March 2, 2011. UCB warned generic competition to its top epilepsy medicine would cause sales and profits to decline this...
View Photo »Susan Axelrod, president of CURE, a non-profit pursuing a cure for epilepsy, and wife of former White House advisor David Axelrod (in center), joined by Prof. Isaac Kohlberg, Chief Technology Officer, Harvard University (on left), and Prof. Ismail Kola, President, UCB NewMedicines (on...
View Photo »BEVERLY HILLS, CA - MAY 12: Executive Council Chairman of Lupus LA Adam Selkowitz (L) with UCB Medical Visionary Honorees arrive at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »A pharmacist holds up a box of Distilbene (diéthylstilboestrol or DES), on September 24, 2009 in Paris. Women suffering from cancer after being exposed in utero to the drug will no longer have to prove which brand of the drug their mother took during pregnancy, a court ruled today. ...
View Photo »BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB speaks onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »So we [the board] unanimously decided to give him a pension and gift for a job well done. UCB gave him R5-million
At no stage since my retirement has the UCB or CSA made any contribution to my medical aid
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
At UCB, we are committed to working toward improving the lives of people living with epilepsy
UCB New Medicines™ is deploying a wide range of innovative and proprietary science and technologies in its search for breakthrough medicines. Lectus’s drug discovery and development programmes supports our research efforts in the CNS field. I feel confident it will enable us to further honour our commit...
I did some stuff in high school and then I saw a really cool show that was like a UCB showcase ... I asked them how to get involved and they told me to go take classes. So pretty much, you go to the UCB in New York and start taking classes and you’re in.
I did some stuff in high school and then I saw a really cool show that was like a UCB showcase ... I asked them how to get involved and they told me to go take classes. So pretty much, you go to the UCB in New York and start taking classes and you’re in.
